More on MKKGY

- Summary
- Chart
- Profile
- Historical

Data

- Ratings (0.0 Score)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(OP:MKKGY)
Delayed: 31.64 -0.06 (0.19%)
Prev. Close $31.70  
Open$31.96 
52 Wk High$ 
52 Wk Low$ 
Day High$31.98 
Day Low$31.64 
P/E N/A  
EPS$ 
Volume41,656 

Friends, Peers and Foes (?): MRK, SWTX, MRCG, MKGAF MRKC (more...)

Jul 16, 2026 08:11 AM MilliporeSigma Announces Opening of BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe
Jul 8, 2026 08:00 AM FDA grants breakthrough designation to EMD Serono's lupus drug enpatoran
Jul 8, 2026 08:00 AM EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations
Jun 24, 2026 08:15 AM EMD Serono names new global commercial head and North America president
Jun 24, 2026 08:15 AM EMD Serono Announces Healthcare Leadership Changes for Global Commercial Strategy and North America
Jun 23, 2026 09:30 AM Merck KGaA, Darmstadt, Germany, Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies
Jun 8, 2026 08:00 AM MilliporeSigma Appoints New Heads of Discovery Solutions and Strategy & Business Development
May 21, 2026 08:01 AM Merck KGaA begins phase 3 trial for colorectal cancer drug
May 21, 2026 08:00 AM Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
May 12, 2026 09:00 PM Is Merck KGaA’s healthcare business facing a major test in 2026
View All Articles

Entities mentioned with MKKGY

View All Entities